Joanna Moncrieff

Joanna Moncrieff is a British psychiatrist, researcher, and leading critic of the biomedical model of psychiatric drug treatment. As a practicing consultant psychiatrist at the North East London NHS Foundation Trust and professor of Critical and Social Psychiatry at University College London, she has extensively researched psychiatric drug effects and the history of psychiatric drug development. Her work challenges conventional theories about chemical imbalances and psychiatric medications, particularly antidepressants and antipsychotics. Moncrieff developed the "drug-centered" model of psychiatric drug action as an alternative to the "disease-centered" model, arguing that psychiatric drugs work by creating altered mental states rather than correcting underlying chemical abnormalities. Through books like "The Myth of the Chemical Cure" and "A Straight Talking Introduction to Psychiatric Drugs," Moncrieff has contributed significantly to academic and public discourse on mental health treatment. Her research has appeared in leading medical journals and she co-founded the Critical Psychiatry Network, which examines the philosophical basis of psychiatric practice. She frequently engages in public debate about psychiatric drug use and mental health treatment, advocating for more careful consideration of psychiatric drug effects and alternative approaches to mental health care. Moncrieff's work has influenced both clinical practice and policy discussions about the role of medication in mental health treatment.

Readers view Moncrieff as a challenger to mainstream psychiatric practices, with reviews focusing on her evidence-based critique of medication-centered mental health treatment. What readers liked: - Clear presentation of research and data - Practical alternatives to long-term medication - Detailed examination of drug studies and their limitations Amazon reviewers note her "meticulous research" and "accessible writing style" for complex topics. What readers disliked: - Some find her stance too absolute against medications - Medical professionals criticize her interpretation of certain studies - Limited discussion of cases where medications helped patients Ratings across platforms: - Goodreads: 4.2/5 (The Myth of the Chemical Cure) - Amazon: 4.5/5 (A Straight Talking Introduction to Psychiatric Drugs) - Google Books: 4.3/5 (average across titles) Several mental health professionals and patients credit her work for changing their approach to treatment. Critical reviews often come from traditional psychiatrists who disagree with her fundamental premises about drug action and effectiveness.

The Myth of the Chemical Cure: A Critique of Psychiatric Drug Treatment (2008) Examines the evidence and theoretical basis of drug treatment in psychiatry, arguing against the disease-centered model of drug action.

A Straight Talking Introduction to Psychiatric Drugs (2009) Provides information about major psychiatric drugs, their effects, and how they are used in modern mental health treatment.

The Bitterest Pills: The Troubling Story of Antipsychotic Drugs (2013) Traces the history of antipsychotic drugs and analyzes their impact on patients and modern psychiatric practice.

A Straight Talking Introduction to the Power Threat Meaning Framework (2020) Explains an alternative framework for understanding mental distress that focuses on social and psychological factors rather than biological causes.

The Political Economy of the Mental Health System (2023) Analyzes how economic and political factors have shaped mental health services and the pharmaceutical industry's influence on psychiatric practice.

Peter Gøtzsche writes about pharmaceutical industry influence on psychiatry and critiques medication-based approaches to mental health. His work examines clinical trial data and questions standard psychiatric practices.

Robert Whitaker investigates the history of psychiatric treatments and outcomes in mental health care. His research focuses on long-term effects of psychiatric drugs and the rise of disability rates.

Peter Breggin examines psychiatric drug effects and advocates for non-drug approaches to mental health treatment. He writes about withdrawal from psychiatric medications and challenges to the chemical imbalance theory.

David Healy researches pharmaceutical industry practices and drug safety issues in psychiatry. His work covers the history of psychopharmacology and problems with clinical trial reporting.

James Davies analyzes the sociological aspects of psychiatry and medicalization of human experiences. He writes about the expansion of psychiatric diagnosis and the influence of corporate interests in mental health care.